Commonwealth Equity Services’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $656K | Buy |
|
|||||
|
2025
Q2 | $383K | Buy |
|
|||||
|
2025
Q1 | $448K | Buy |
|
|||||
|
2024
Q4 | $621K | Sell |
|
|||||
|
2024
Q3 | $547K | Buy |
|
|||||
|
2024
Q2 | $579K | Buy |
|
|||||
|
2024
Q1 | $814K | Buy |
|
|||||
|
2023
Q4 | $684K | Buy |
|
|||||
|
2023
Q3 | $107K | Buy |
|
|||||
|
2023
Q2 | $131K | Buy |
|
|||||
|
2023
Q1 | $128 | Buy |
|
|||||
|
2022
Q4 | $272K | Hold |
|
|||||
|
2022
Q3 | $211K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $217K | Sell |
|
|||||
|
2021
Q2 | $194K | Buy |
|
|||||
|
2021
Q1 | $168K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $4K | Hold |
|
|||||
|
2018
Q1 | $11K | Buy |
|